Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on German Health Review.
Press releases published on June 2, 2025
AST Launches Enhanced 2025 Industry Patent Purchase Program (IP3) with Group Licensing Option
EIN Presswire
·
June 2, 2025
AST launched its 10th annual IP3 initiative for 2025, connecting patent owners with leading technology companies for streamlined transactions. PRINCETON, NJ, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- Allied Security Trust (AST), a member-driven …
NTVM Honors Harvard University, NMAC, UCC, Gender Liberation, and More at Sold-Out 2025 Labor of Love Awards
EIN Presswire
·
June 2, 2025
NTVM is proud to announce the 2025 Organization Honorees for this years Labor of Love Awards WASHINGTON, DC, DC, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- The National Trans Visibility March (NTVM) is proud to announce the 2025 Labor of Love …
PayToMe.co Joins NVIDIA Inception to Tackle $46B SMB Finance Problem With AI
EIN Presswire
·
June 2, 2025
NVIDIA Inception supports PayToMe.co’s mission to empower 400M SMBs with real-time payments, compliance automation, and global AI infrastructure. SAN FRANCISCO, CA, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- 🚀 PayToMe.co, an award-winning AI- …
MOIN Launches Cross-Border Remittance Service via Toss App, Enhancing Accessibility for 28 Million Users
EIN Presswire
·
June 2, 2025
MOIN, a leading fintech company specializing in cross-border remittance solutions, has launched its cross-border money transfer service on Toss SEOUL, EUNPYEONG, SOUTH KOREA, June 2, 2025 /EINPresswire.com/ -- MOIN, a leading fintech company …
atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Mental Health Therapies
GlobeNewswire
·
June 2, 2025
Strategic combination establishes a market-leading mental health company with a pipeline that includes potentially transformative, rapid-acting psychedelic assets differentiated by their convenient route of administration and short time-in-clinic Combined …
Sandoz launches first and only interchangeable denosumab biosimilars in US, providing new affordable treatment options for over 10 million patients[1]
GlobeNewswire
·
June 2, 2025
Ad-hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE WYOST® (denosumab-bbdz) and Jubbonti® (denosumab-bbdz) are first and only FDA-approved interchangeable denosumab biosimilars available in US Improves access for patients …